GMP IPO Watch
Pramodini Medicare IPO 2026: Final-Day Subscription, ₹63.38 Crore Income, PPP Diagnostics and Expansion Analysis
Pramodini Medicare IPO 2026: Final-Day Subscription, ₹63.38 Crore Income, PPP Diagnostics ...
Read Article
P
SME IPO
LISTED
NSE, BSE
PRAMODINI
Pramodini Medicare IPO
Pramodini Medicare IPO details, live grey market premium (GMP), dates, price band, lot size, subscription & review.
Live GMP Today
₹0
+0.0%
Est. Listing: ₹118.00
Price Band
₹110 - ₹118
Per equity share
Lot Size
1200 Shares
Min Invest: ₹2,83,200
Issue Size
₹69.04 Cr
Total Public Offering
Issue Dates
11 August 2026 – 13 August 2026
Bidding period
Subscription
3.87x
Total overall demand
Pramodini Medicare IPO Details
Key facts at a glance| IPO Open Date | 11 August 2026 | IPO Close Date | 13 August 2026 |
|---|---|---|---|
| Basis of Allotment | 16 August 2026 | Listing Date | 18 August 2026 |
| Price Band | ₹110 - ₹118 per share | Face Value | ₹10 per share |
| Market Lot Size | 1200 Shares | Min Investment (Retail) | ₹2,83,200 |
| Total Issue Size | ₹69.04 Cr | Issue Type | Book Built Issue IPO |
| Fresh Issue | — | Offer for Sale (OFS) | — |
| Listing At | NSE, BSE | Issue Category | SME Issue |
| Registrar | TBA | ||
Pramodini Medicare IPO Timetable (Tentative Dates)
| Event | Tentative Date | Status |
|---|---|---|
| IPO Open Date | 11 August 2026 | Confirmed |
| IPO Close Date | 13 August 2026 | Confirmed |
| Basis of Allotment | 16 August 2026 | Tentative |
| Initiation of Refunds | 18 August 2026 | Tentative |
| Credit of Shares to Demat | 18 August 2026 | Tentative |
| IPO Listing Date | 18 August 2026 | Tentative |
| Cut-off time for UPI Mandate Confirmation | 14 August 2026 (5:00 PM) | Deadline |
* Note: Timelines are tentative and subject to regulatory confirmation. UPI mandate approvals must be completed by 5:00 PM on the IPO closing day.
Pramodini Medicare IPO Lot Size & Investment Details
Application limits for Retail and HNI investors| Application Category | Lots | Shares | Amount (at Cut-off) |
|---|---|---|---|
| Retail (Min) | 2 Lots | 2,400 Shares | ₹2,83,200 |
| Retail (Max) | 2 Lots | 2,400 Shares | ₹2,83,200 |
| S-HNI (Min) | 3 Lots | 3,600 Shares | ₹4,24,800 |
| S-HNI (Max) | 7 Lots | 8,400 Shares | ₹9,91,200 |
| B-HNI (Min) | 8 Lots | 9,600 Shares | ₹11,32,800 |
Pramodini Medicare IPO Live GMP & Movement History
Daily unofficial grey market trends
Current Grey Market Premium
₹0 +0.0%
Estimated Listing Price
₹118.00
| Date | IPO GMP (₹) | Estimated Listing Price | Estimated Listing Gain (%) |
|---|---|---|---|
| 13 Aug 2026 | ₹0 | ₹118.00 | +0.00% |
Disclaimer: Grey Market Premium (GMP) figures are purely unofficial and indicative rates traded in the unregulated grey market. GMP is highly volatile and does not guarantee the actual listing price. Always consult a SEBI registered investment advisor before bidding.
Pramodini Medicare IPO Subscription Status
Demand breakdown by investor category
Retail
3.49x
QIB
3.66x
NII / HNI
4.96x
Total
3.87x
About Pramodini Medicare
Pramodini Medicare Limited is an Indian diagnostic service provider offering a comprehensive range of technology-enabled services, including radiology, clinical laboratory testing, and nuclear medicine. The company serves public and private hospitals, government Public Sector Undertakings (PSUs), and medical colleges across tier I, II, and III cities. Its core offerings are divided into three segments: Radiology (MRI, CT scans, ultrasound), Clinical Laboratory (pathology, microbiology, immunology), and Nuclear Medicine (PET-CT and nuclear therapy). Additionally, it operates a 24×7 teleradiology service from its registered office in Vijayawada. Pramodini Medicare generates revenue by providing routine and specialized tests for prediction, early detection, and disease monitoring. The business uniquely operates across four key models: Public-Private Partnerships (PPP) with government hospitals, Private-Private Partnerships, strategic alliances with PSUs, and standalone private centres. This diversified approach enables the company to deliver widespread preventative and diagnostic healthcare solutions across India.
Key Strengths
- The business model spans PPP, private hospitals, PSUs, and standalone centres.
- The diagnostic network grew from 1 centre in FY15 to 16 centres today.
- Offers specialized services across radiology, clinical laboratory, and nuclear medicine.
- Revenue grew significantly from ₹3,522.95 lakhs in FY24 to ₹6,228.75 lakhs in FY26.
- Leverages public health infrastructure through extensive government MOUs.
Key Risks
- High dependence on government PPP MOUs subject to non-renewal or delayed payments.
- Focus on capital-intensive radiology exposes the firm to equipment and regulatory risks.
- Over 60% revenue concentration in Andhra Pradesh creates geographic risk.
- Loss of top institutional clients could severely impair revenue and profitability.
- Past statutory filing delays and non-compliances expose the firm to regulatory penalties.
Pramodini Medicare IPO Reservation & Share Quotas
The Pramodini Medicare IPO has allocated shares across Anchor Investors, Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors. The reservation structure determines the number and percentage of shares available for each investor category.
Anchor investors have been allocated 13,60,800 shares, representing 23.26% of the issue. The QIB category excluding anchor investors has been allocated 11,71,200 shares, while 9,60,000 shares are available for NIIs. Retail investors have been offered 20,23,200 shares, representing 34.58% of the issue.
| Investor Category | Shares Offered | Reservation (%) |
|---|---|---|
| Anchor Investor | 13,60,800 Shares | 23.26% |
| Qualified Institutional Buyers (QIB) (Ex. Anchor) | 11,71,200 Shares | 20.02% |
| Non-Institutional Investors (NII) | 9,60,000 Shares | 16.41% |
| Retail Individual Investors (RII) | 20,23,200 Shares | 34.58% |
Note: The above table presents the category-wise IPO reservation details. Final allotment to investors will depend on the subscription received in each category and the basis of allotment finalized after the IPO closes.
Pramodini Medicare IPO Anchor Investors
The Pramodini Medicare IPO anchor investor bidding was scheduled for August 11, 2026, one day before the public issue opened for subscription. Anchor investors form part of the institutional allocation and participate in the IPO before the issue becomes available to other investor categories.
The final anchor investor list, number of shares allocated, anchor issue size, and applicable lock-in dates can be updated once the complete anchor allocation information is available.
| Particular | Details |
|---|---|
| Anchor Bidding Date | August 11, 2026 |
| Anchor Investors List | To be Updated |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| Lock-in Period End Date – 50% Shares (30 Days) | 2026 |
| Lock-in Period End Date – Remaining 50% Shares (90 Days) | 2026 |
Note: The anchor investor names, final shares offered, anchor size, and exact 30-day and 90-day lock-in expiry dates should be updated once the final anchor allocation details are available.
Pramodini Medicare IPO Important Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 12 Aug 2026 |
| IPO Close Date | 14 Aug 2026 |
| Basis of Allotment | 17 Aug 2026 |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 19 Aug 2026 |
Note: The timeline for Pramodini Medicare IPO is tentative and subject to change.
Pramodini Medicare Promoters and Shareholding Pattern
The promoters of Pramodini Medicare are Dr. Chalasani Kuldeep Kumar, Dr. Chalasani Kavitha, Ms. Chalasani Durga Aashritha and M/s. Sri Ram Medicare Private Limited. Before the IPO, the promoter and promoter group collectively hold 85.71% of the company's equity share capital.
Following the IPO, the promoter and promoter group's shareholding is expected to decline to 62.64%, while the shareholding of other investors is expected to increase from 14.29% to 37.36%. The company's total equity shares are expected to increase from 1,66,94,795 shares before the IPO to 2,20,45,595 shares after the issue.
Promoters of Pramodini Medicare
- Dr. Chalasani Kuldeep Kumar
- Dr. Chalasani Kavitha
- Ms. Chalasani Durga Aashritha
- M/s. Sri Ram Medicare Private Limited
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
|---|---|---|---|---|
| Promoter and Promoter Group | 1,43,09,477 | 85.71% | 1,38,09,077 | 62.64% |
| Others* | 23,85,318 | 14.29% | 82,36,518 | 37.36% |
| Total | 1,66,94,795 | 100% | 2,20,45,595 | 100% |
Note: The above table presents the pre-IPO and proposed post-IPO shareholding pattern of Pramodini Medicare. The promoter group's holding is expected to decrease from 85.71% before the issue to 62.64% after completion of the IPO.
Pramodini Medicare Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Pramodini Medicare About the IPO
Pramodini Medicare Limited, founded in 2000, is one of the leading diagnostic services providers in India across radiology, clinical laboratory, and nuclear medicine segments. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.
Pramodini Medicare operates diagnostic centres through Public-Private Partnerships (PPP), Private-Private Partnerships (Pvt-Pvt), Strategic Partnerships with PSUs, Standalone Diagnostic Centres, and Location-Specific Agreements. The firm has its presence across Vijayawada, Hyderabad, Kurnool, Kapada, Tirupati, Varanasi, Prayagraj, and many others.
Pramodini Medicare Company Financial Report
To Be Updated Soon
Pramodini Medicare Company Valuation & Key Performance Indicators
To Be Updated Soon
Pramodini Medicare Peer Group Comparison
To Be Updated Soon
Pramodini Medicare Lead Managers & Merchant Bankers
- Smart Horizon Capital Advisors Pvt.Ltd.
Pramodini Medicare IPO FAQs
Pramodini Medicare IPO opens for subscription on 11 August 2026 and closes on 13 August 2026.
The price band for Pramodini Medicare IPO is set at ₹110.00 to ₹118.00 per share.
The minimum market lot size is 1200 shares. A retail investor can apply for a minimum of 1 lot requiring an investment of 2,400 Shares (₹2,83,200).
The latest Grey Market Premium (GMP) for Pramodini Medicare IPO is ₹0. GMP represents the unofficial premium at which shares trade prior to listing.
The basis of allotment for Pramodini Medicare IPO is tentatively scheduled for 16 August 2026, and shares are expected to list on the stock exchanges on 18 August 2026.
The registrar details will be confirmed in the official prospectus.
Pramodini Medicare IPO Analysis & Articles
